SCHEMBL24341096

SCHEMBL24341096

c1ccc2c(c1)oc1cc(-c3c4ccccc4c(-c4ccc5oc6c(c5c4)c4ccccc4c4sc5ccccc5c64)c4ccccc34)ccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR2 Q92731 2/20 0.38
▸ ESR1 P03372 1/20 0.34
▸ PRKDC P78527 2/20 0.34
▸ AHR P35869 2/20 0.34
▸ MEN1 O00255 4/20 0.33
▸ MAPT P10636 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ NPC1 O15118 1/20 0.31
▸ RAB9A P51151 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ ALOX5 P09917 2/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ ALPI P09923 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ CASP3 P42574 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19110093 0.93 ESR2 (0.39) ESR2ESR1PRKDCAHRMEN1
SCHEMBL19110098 0.90 PRKDC (0.40) ESR2ESR1PRKDCAHRMEN1
SCHEMBL24341754 0.90 ESR2 (0.36) ESR2ESR1PRKDCMAPTHPGD
SCHEMBL17944945 0.88 AHR (0.37) ESR2ESR1PRKDCAHRMEN1
SCHEMBL24341645 0.86 NPC1 (0.35) ESR2ESR1PTPN1NPC1RAB9A
SCHEMBL19110300 0.86 AHR (0.35) ESR2ESR1PRKDCAHRMEN1
SCHEMBL17944250 0.86 AHR (0.37) ESR2ESR1PRKDCAHRMEN1
SCHEMBL19110316 0.86 AHR (0.39) ESR2ESR1PRKDCAHRMEN1
SCHEMBL19110298 0.84 PTPN1 (0.39) ESR2ESR1PRKDCAHRMEN1
SCHEMBL17944898 0.84 AHR (0.38) ESR2ESR1PRKDCAHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2022-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11276827-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ESR2 510/4885ESR1 153/4885PRKDC 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback